Baird Melissa's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Nov 8, 2023
- Accession no.
- 0001773751-23-000280
- Filed
- Nov 8, 2023, 7:21 PM ET
- Trade date
- Nov 6-8, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $187.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Baird MelissaCIK 0001837815 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2023 | Class A Common Stock | MOption exerciseAcquired | +9,133 | $0.40 | +$3,653.2 | 412,982 | Direct | |
| Nov 6, 2023 | Class A Common Stock | SSaleDisposed | −9,133 | $6.34F2 | −$57,947.97 | 403,849 | Direct | |
| Nov 7, 2023 | Class A Common Stock | MOption exerciseAcquired | +9,133 | $0.40 | +$3,653.2 | 412,982 | Direct | |
| Nov 7, 2023 | Class A Common Stock | SSaleDisposed | −9,133 | $7.07F3 | −$64,539.26 | 403,849 | Direct | |
| Nov 8, 2023 | Class A Common Stock | MOption exerciseAcquired | +9,133 | $0.40 | +$3,653.2 | 412,982 | Direct | |
| Nov 8, 2023 | Class A Common Stock | SSaleDisposed | −9,133 | $7.09F4 | −$64,734.7 | 403,849 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2023 | Class A Common Stock | MOption exerciseDisposed | −9,133 | $0.00 | $0 | 832,554 | Direct | |
| Nov 7, 2023 | Class A Common Stock | MOption exerciseDisposed | −9,133 | $0.00 | $0 | 823,421 | Direct | |
| Nov 8, 2023 | Class A Common Stock | MOption exerciseDisposed | −9,133 | $0.00 | $0 | 814,288 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $6.24 - $6.64. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $6.87 - $7.39. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $6.94 - $7.37. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.